Perhaps the best option for the first stage is to detect high frequency mutations of GJB2, STRC, USH2A, and SLC26A4 genes (including CNVs), which is probably to detect two mutations in a significant proportion of patients with NSHL using MLPA methods. Here, USH2A is linked to nodular sclerosis classical Hodgkin lymphoma.